Sign In
Buy ICCM
$0.152
+0.0127 (+9.14%)
At Close: Jun 03, 2026
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
08:30am, Tuesday, 02'nd Jun 2026
Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy CAESAREA, ISRAEL, June 2, 2026 /PRNewswire/ -- IceCure Medical Ltd. (the "Company" or "IceCure" or
At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors ≤3 cm and 83.9% of patients remained recurrence
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
04:30pm, Wednesday, 13'th May 2026
No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares CAESAREA, Israel, May 13, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or t
IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript
12:40pm, Tuesday, 12'th May 2026
IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates
10:41am, Tuesday, 12'th May 2026
IceCure Medical Ltd. (ICCM) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.03.
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America
08:30am, Tuesday, 12'th May 2026
Pent-up demand immediately following FDA clearance generates 46% increase in active customer accounts using ProSense® as of the end of the first quarter 2026, compared with prior to FDA clearance Acc
IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026
08:30am, Wednesday, 06'th May 2026
CAESAREA, Israel, May 6, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys
As the only FDA cleared minimally invasive treatment option for low-risk breast cancer, ProSense® is aligned with the trend toward de-escalation of breast cancer treatment—a key theme at this year'
The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical conferences are timely as commercial momentum accelerates Cryoablation cost analysis study from Massac
Reviewing IceCure Medical (NASDAQ:ICCM) and Pediatrix Medical Group (NYSE:MD)
02:13am, Sunday, 29'th Mar 2026
Pediatrix Medical Group (NYSE: MD - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two c
Head-To-Head Analysis: Biocorrx (OTCMKTS:BICX) and IceCure Medical (NASDAQ:ICCM)
02:36am, Friday, 27'th Mar 2026
IceCure Medical (NASDAQ: ICCM - Get Free Report) and Biocorrx (OTCMKTS:BICX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two compan
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement
08:00am, Thursday, 26'th Mar 2026
CAESAREA, Israel, March 26, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destr
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
08:30am, Wednesday, 25'th Mar 2026
At a median follow-up of four years, 89.4% recurrence-free rate in patients with tumors ≤3 cm and no prior kidney cancer; 83.9% recurrence-free rate for general study population Full analysis of res
IceCure Appoints Meir Peleg as Chief Financial Officer
08:30am, Tuesday, 24'th Mar 2026
Meir Peleg brings over 20 years of financial leadership and experience including with Nasdaq listed companies IceCure intends to appoint Dr. Richard Fine as Medical Director CAESAREA, Israel, March 24
Analyzing IceCure Medical (NASDAQ:ICCM) & Danaher (NYSE:DHR)
02:15am, Sunday, 22'nd Mar 2026
Danaher (NYSE: DHR - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on t
